United States: Third Circuit Rejects Presumption Of Irreparable Harm In Lanham Act Cases

In a precedential decision issued this week, Ferring Pharmaceuticals v. Watson Pharmaceuticals, the U.S. Court of Appeals for the Third Circuit joined the Ninth Circuit in rejecting the presumption of irreparable harm for plaintiffs seeking a preliminary injunction in Lanham Act false advertising and trademark infringement cases.

While most courts have discarded the presumption of irreparable harm in patent or copyright cases following the United States Supreme Court's decisions in eBay v. MercExchange, 547 U.S. 403 (2006), and Winter v. Natural Resources Defense Council, 555 U.S. 7 (2008), application of the presumption in the trademark context has been inconsistent—due in large part to differences between trademark and other intellectual property rights.

A petition for certiorari in the Ninth Circuit's decision on this issue is currently pending before the U.S. Supreme Court and could provide needed guidance in this area of the law. Until then, trademark litigants in the Third Circuit need to be mindful of the court's newly pronounced position in determining strategy in Lanham Act cases.

The Presumption

Before 2006, it was well established that a Lanham Act plaintiff seeking a preliminary injunction in a trademark infringement case earned a presumption of irreparable harm upon a showing of likelihood of success on the merits. The rebuttable evidentiary presumption arises from the premise that harms caused by false advertising and trademark violations are noneconomic and intangible. A trademark owner's reputation, loss of control, or goodwill-based injury is distinct from a copyright or patent owner's economic injury. The Lanham Act prohibits a mere likelihood of confusion, and a trademark owner's injury cannot be readily measured by diverted sales or disgorgement of a defendant's ill-gotten gain and is inherently irreparable. By the time that actual injury to goodwill has occurred or the harm can be quantified, courts have found that it may be too late.

Trademark cases are also different because courts have held that in addition to the protection afforded to the trademark owner, the presumption of irreparable harm benefits the consuming public. A preliminary injunction is seen by some as a way to correct misinformation in the market as quickly as possible, allowing the public to accurately identify brands and distinguish among products.

Background and Procedural History of Ferring

The dispute between Ferring and Watson, competing pharmaceutical companies, arose from alleged false statements made about Ferring's product during a presentation hosted by Watson. Ferring filed a complaint asserting false advertising claims under the Lanham Act and state law based on Watson's statements. Ferring also sought a preliminary injunction to prevent Watson from making further false statements about Ferring's competing product, Endometrin®.

Ferring presented evidence that the presenter had referenced a "Black Box" warning for Endometrin®, suggesting that Endometrin® carries a significant risk of serious or life-threatening effects even though the drug actually had no such warning. Ferring also alleged that the presenter mischaracterized studies showing the effectiveness of Endometrin® in women over the age of 35, stating that "the efficacy has not been demonstrated" when the Endometrin® package insert actually stated that "[e]fficacy in women 35 years of age and older has not been clearly established." (Emphasis added.) Finally, Ferring showed that the presenter improperly presented patient survey data as if it were a comparison of the two products, even though the survey did not actually compare patient preferences. With respect to each statement, the presenter certified to the District Court that he would not repeat the statements in the future.

The District Court denied Ferring's request for injunctive relief, finding that Ferring was not entitled to a presumption of irreparable harm and that without such presumption, Ferring had failed to put forth sufficient evidence to demonstrate a likelihood of irreparable harm. (Notably, the District Court avoided a decision regarding likelihood of success on the merits by instead finding that Ferring had failed to demonstrate irreparable harm. Because Watson had put forth evidence supporting its statements, the District Court commented that it was not clear that Watson's allegedly false statements were "completely unsubstantiated" so as to be per se false under Third Circuit precedent and to support a finding of likelihood of success. The court stated that it "need not make a determination as to the likelihood of success of Ferring's claims, because, as mentioned above, Ferring has failed to demonstrate irreparable harm.")

On appeal, the U.S. Court of Appeals for the Third Circuit found no clear error. The court acknowledged that it had permitted the presumption of irreparable harm for Lanham Act trademark actions prior to eBay and Winter, based on the fact that injuries in the trademark context such as loss of control, reputation, or goodwill were irreparable. However, there was no analogous Third Circuit precedent with respect to Lanham Act false advertising claimants. Nevertheless, the court went on to hold that, based on the reasoning of eBay and Winter, Lanham Act plaintiffs are no longer entitled to a presumption of irreparable harm when seeking preliminary injunctive relief. The Third Circuit reasoned that the Lanham Act's injunctive relief provision, like the Patent Act's provision, is premised on traditional principles of equity, and therefore the Lanham Act should be interpreted in the same manner as the Patent Act in eBay. Accordingly, since traditional principles of equity require a movant to demonstrate irreparable harm, allowing a presumption deviates from these principles.

The Third Circuit went on to analyze Ferring's evidence of irreparable harm and held that it was insufficient to warrant injunctive relief. The Third Circuit found it significant that Watson's Dr. Silverberg certified to the court that he would not make the statements in the future and that Watson had removed the statements from the webcast of the presentation. The Third Circuit noted that there was no evidence that the allegedly false statements were still available to customers. Finally, the Third Circuit found "speculative" a declaration from a doctor that he and other doctors would be less likely to prescribe Ferring's drug if it contained the Black Box warning that Watson had asserted in its presentation.

The Circuit Split

In Herb Reed Enterprises v. Florida Entertainment Management, 736 F.3d 1239 (9th Cir. 2013), the Ninth Circuit became the first circuit to affirmatively state that the presumption of irreparable harm was no longer valid in the trademark context. (The court in Herb Reed did acknowledge that "[e]vidence of loss of control over business reputation and damage to goodwill could constitute irreparable harm." 736 F.3d at 2011.) The Third Circuit in Ferring agreed with the Ninth Circuit's rejection of the presumption and its rationale on this issue. In contrast, the Fifth Circuit in Abraham v. Alpha Chi Omega, 708 F.3d 614 (5th Cir. 2013), cited eBay and then determined that it was not erroneous for a lower court to grant a preliminary injunction in a trademark infringement case by presuming irreparable injury once the plaintiff had shown a likelihood of confusion. Id. at 627.

Other circuits have commented on the issue but have not yet made a determination one way or the other. For example, the Eleventh Circuit noted in dicta that "a strong case can be made" that eBay's holding would extend to Lanham Act cases, but it "decline[d] to decide whether the district court was correct in its holding that the nature of the trademark infringement gives rise to a presumption of irreparable injury." N. Am. Med. Corp. v. Axiom Worldwide, Inc., 522 F.3d 1211, 1228 (11th Cir. 2008).

What to Watch For

If the petition for certiorari in Herb Reed is denied, the state of the law regarding presumption of harm in trademark cases will continue to be a circuit-by-circuit analysis and could very well depend upon the type of Lanham Act claim brought.

Lanham Act defendants emphasize that evidence as to likelihood of confusion should not lead to a presumption of irreparable harm. Defendants in the Third Circuit might also attempt to avoid a preliminary injunction by certifying that they will cease making the challenged statement.

Lanham Act plaintiffs argue that failure to retain the presumption may present an insurmountable burden of proof because evidence of actual irreparable harm can be difficult to show at early stages in litigation. Courts denying the presumption offer little guidance as to what evidence does support a finding of irreparable harm. A plaintiff may accordingly find it beneficial to bring Lanham Act claims in those jurisdictions that have not applied eBay in the trademark context. Nevertheless, a plaintiff will want to be prepared to present evidence to support a finding of irreparable harm. Such evidence may include instances of actual confusion, a consumer survey demonstrating confusion, loss of control, evidence of inferior goods offered under the infringing mark, decline in market share, loss of customers, lost sales attributable to alleged false statements or infringing trademarks, or reputational harm.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions